Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies (Details)

v3.23.1
Significant Accounting Policies (Details)
$ in Millions
12 Months Ended
Jan. 01, 2023
shares
Jan. 01, 2022
shares
Dec. 31, 2023
shares
Dec. 31, 2022
USD ($)
segment
shares
Dec. 31, 2021
USD ($)
shares
Mar. 17, 2015
Significant Accounting Policies            
Percentage of shares issued for offering and annual equity fee           2.50%
Number of operating segments       1    
Number of reportable segments       1    
Fortress Biotech, Inc            
Significant Accounting Policies            
Percentage of shares issued for offering and annual equity fee 2.50% 2.50%        
Number of shares issued | shares 368,907 212,142 368,907 56,671 29,749  
Research and development            
Significant Accounting Policies            
Value of common stock shares issued | $       $ 1.9 $ 6.6